Trial intelligence / Profile preview

Fentanyl + midazolam versus ketamine + midazolam for procedural sedation in children with cancer

TCTR20200807001Phase 3Completed

Sponsor
Phramongkutklao Hospital and College of Medicine
Start
Aug 2018
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fentanyl, midazolam, ketamine in cancer, sponsored by Phramongkutklao Hospital and College of Medicine. Started Aug 2018; status: completed.

02

Drugs

fentanylmidazolamketamine
03

Conditions

cancer

Beyond the preview

Go deeper on TCTR20200807001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200807001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call